...
首页> 外文期刊>The Journal of rheumatology >Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets
【24h】

Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets

机译:我们可以决定在每个临床试验中应该测量哪些结果吗?对现有概念框架和流程进行范围界定的审查,以开发核心成果集

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. The usefulness of randomized control trials to advance clinical care depends upon the outcomes reported, but disagreement on the choice of outcome measures has resulted in inconsistency and the potential for reporting bias. One solution to this problem is the development of a core outcome set: a minimum set of outcome measures deemed critical for clinical decision making. Within rheumatology the Outcome Measures in Rheumatology (OMERACT) initiative has pioneered the development of core outcome sets since 1992. As the number of diseases addressed by OMERACT has increased and its experience in formulating core sets has grown, clarification and update of the conceptual framework and formulation of a more explicit process of area/domain core set development has become necessary. As part of the update process of the OMERACT Filter criteria to version 2, a literature review was undertaken to compare and contrast the OMERACT conceptual framework with others within and outside rheumatology. Methods. A scoping search was undertaken to examine the extent, range, and nature of conceptual frameworks for core set outcome selection in health. We searched the following resources: Cochrane Library Methods Group Register; Medline; Embase; PsycInfo; Environmental Studies and Policy Collection; and ABI/INFORM Global. We also conducted a targeted Google search. Results. Five conceptual frameworks were identified: the WHO tripartite definition of health; the 5 Ds (discomfort, disability, drug toxicity, dollar cost, and death); the International Classification of Functioning (ICF); PROMIS (Patient-Reported Outcomes Measurement System); and the Outcomes Hierarchy. Of these, only the 5 Ds and ICF frameworks have been systematically applied in core set development. Outside the area of rheumatology, several core sets were identified; these had been developed through a limited range of consensus-based methods with varying degrees of methodological rigor. None applied a framework to ensure content validity of the end product. Conclusion. This scoping review reinforced the need for clear methods and standards for core set development. Based on these findings, OMERACT will make its own conceptual framework and working process more explicit. Proposals for how to achieve this were discussed at the OMERACT 11 conference.
机译:目的。随机对照试验对改善临床治疗的有效性取决于所报告的结果,但是对结果测量方法的选择分歧导致不一致和报告偏见的可能性。解决此问题的一种方法是开发核心结果集:认为对临床决策至关重要的最小量度结果集。自1992年以来,在风湿病学领域,风湿病治疗措施(OMERACT)计划开创了核心结局的开发。随着OMERACT处理的疾病数量的增加,其在制定核心结局方面的经验不断增长,概念框架和说明的更新和更新制定更明确的区域/域核心集开发过程已成为必要。作为OMERACT过滤器标准到版本2更新过程的一部分,进行了文献综述,以比较和对比OMERACT概念框架与风湿病学内部和外部的其他框架。方法。进行了范围界定搜索,以检查卫生领域核心结果选择的概念框架的范围,范围和性质。我们搜索了以下资源:Cochrane库方法组注册; Medline; Embase; PsycInfo;环境研究与政策收集;和ABI / INFORM Global。我们还进行了有针对性的Google搜索。结果。确定了五个概念框架:世卫组织对健康的三方定义; 5 Ds(不适,残疾,药物毒性,美元成本和死亡);国际功能分类(ICF); PROMIS(患者报告的结果测量系统);和结果层次结构。其中,只有5个D和ICF框架已系统地应用于核心集开发。在风湿病学领域之外,确定了几个核心组。这些是通过有限范围的基于共识的方法开发出来的,这些方法具有不同程度的方法严谨性。没有人采用框架来确保最终产品的内容有效性。结论。这项范围界定审查进一步强调了针对核心集开发的明确方法和标准的需求。基于这些发现,OMERACT将使自己的概念框架和工作过程更加明确。在OMERACT 11大会上讨论了如何实现这一目标的提案。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号